Annette Mathisen

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

S Aronoff, Sidney Rosenblatt, Susan S. Braithwaite et al. · Diabetes Care · 2000 · 629 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study

Daniel Einhorn, Marc Rendell, James L. Rosenzweig et al. · Clinical Therapeutics · 2000 · 369 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Susan L. Greenspan, Henry G. Bone, Mark P. Ettinger et al. · Annals of Internal Medicine · 2007 · 360 citations

Medicine, Endocrinology, Orthopedic Surgery +17

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

Mark Kipnes, Arthur Krosnick, Marc Rendell et al. · The American Journal of Medicine · 2001 · 281 citations

Medicine, Pharmacology, Pharmacotherapy +14

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11